286 related articles for article (PubMed ID: 16359856)
1. p63: oncogene or tumor suppressor?
Mills AA
Curr Opin Genet Dev; 2006 Feb; 16(1):38-44. PubMed ID: 16359856
[TBL] [Abstract][Full Text] [Related]
2. p63: Molecular complexity in development and cancer.
Westfall MD; Pietenpol JA
Carcinogenesis; 2004 Jun; 25(6):857-64. PubMed ID: 15033906
[TBL] [Abstract][Full Text] [Related]
3. p63 expression is associated with p53 loss in oral-esophageal epithelia of p53-deficient mice.
Suliman Y; Opitz OG; Avadhani A; Burns TC; El-Deiry W; Wong DT; Rustgi AK
Cancer Res; 2001 Sep; 61(17):6467-73. PubMed ID: 11522642
[TBL] [Abstract][Full Text] [Related]
4. Differential recognition of response elements determines target gene specificity for p53 and p63.
Osada M; Park HL; Nagakawa Y; Yamashita K; Fomenkov A; Kim MS; Wu G; Nomoto S; Trink B; Sidransky D
Mol Cell Biol; 2005 Jul; 25(14):6077-89. PubMed ID: 15988020
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the p63/p73L/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers.
Hagiwara K; McMenamin MG; Miura K; Harris CC
Cancer Res; 1999 Sep; 59(17):4165-9. PubMed ID: 10485447
[TBL] [Abstract][Full Text] [Related]
6. p63 and epithelial biology.
Barbieri CE; Pietenpol JA
Exp Cell Res; 2006 Apr; 312(6):695-706. PubMed ID: 16406339
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of p63 isoforms in female reproductive organs.
Kurita T; Cunha GR; Robboy SJ; Mills AA; Medina RT
Mech Dev; 2005 Sep; 122(9):1043-55. PubMed ID: 15922574
[TBL] [Abstract][Full Text] [Related]
8. P63 gene mutations and human developmental syndromes.
Brunner HG; Hamel BC; Bokhoven Hv Hv
Am J Med Genet; 2002 Oct; 112(3):284-90. PubMed ID: 12357472
[TBL] [Abstract][Full Text] [Related]
9. TA-p63-gamma regulates expression of DeltaN-p63 in a manner that is sensitive to p53.
Li N; Li H; Cherukuri P; Farzan S; Harmes DC; DiRenzo J
Oncogene; 2006 Apr; 25(16):2349-59. PubMed ID: 16331262
[TBL] [Abstract][Full Text] [Related]
10. Contribution of p53, p63, and p73 to the developmental diseases and cancer.
Tomkova K; Tomka M; Zajac V
Neoplasma; 2008; 55(3):177-81. PubMed ID: 18348649
[TBL] [Abstract][Full Text] [Related]
11. The p53-homologue p63 may promote thyroid cancer progression.
Malaguarnera R; Mandarino A; Mazzon E; Vella V; Gangemi P; Vancheri C; Vigneri P; Aloisi A; Vigneri R; Frasca F
Endocr Relat Cancer; 2005 Dec; 12(4):953-71. PubMed ID: 16322335
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of p63 and p53 expression in tissue microarrays of malignant melanomas.
Brinck U; Ruschenburg I; Di Como CJ; Buschmann N; Betke H; Stachura J; Cordon-Cardo C; Korabiowska M
Int J Mol Med; 2002 Dec; 10(6):707-11. PubMed ID: 12429996
[TBL] [Abstract][Full Text] [Related]
13. p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate.
Kunisaki R; Ikawa S; Maeda T; Nakazaki Y; Kurita R; Harata M; Shutoh Y; Bai YS; Soda Y; Tanabe T; Dohi T; Kato R; Ikawa Y; Asano S; Tani K
J Gene Med; 2006 Sep; 8(9):1121-30. PubMed ID: 16832836
[TBL] [Abstract][Full Text] [Related]
14. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family.
Flores ER; Sengupta S; Miller JB; Newman JJ; Bronson R; Crowley D; Yang A; McKeon F; Jacks T
Cancer Cell; 2005 Apr; 7(4):363-73. PubMed ID: 15837625
[TBL] [Abstract][Full Text] [Related]
15. Mutant p53 gain of oncogenic function: in vivo evidence, mechanism of action and its clinical implications.
Adhikari AS; Iwakuma T
Fukuoka Igaku Zasshi; 2009 Jun; 100(6):217-28. PubMed ID: 19670804
[TBL] [Abstract][Full Text] [Related]
16. The transactivating isoforms of p63 are overexpressed in high-grade follicular lymphomas independent of the occurrence of p63 gene amplification.
Pruneri G; Fabris S; Dell'Orto P; Biasi MO; Valentini S; Del Curto B; Laszlo D; Cattaneo L; Fasani R; Rossini L; Manzotti M; Bertolini F; Martinelli G; Neri A; Viale G
J Pathol; 2005 Jul; 206(3):337-45. PubMed ID: 15887287
[TBL] [Abstract][Full Text] [Related]
17. p63 is an essential proapoptotic protein during neural development.
Jacobs WB; Govoni G; Ho D; Atwal JK; Barnabe-Heider F; Keyes WM; Mills AA; Miller FD; Kaplan DR
Neuron; 2005 Dec; 48(5):743-56. PubMed ID: 16337913
[TBL] [Abstract][Full Text] [Related]
18. DeltaNp63 plays an anti-apoptotic role in ventral bladder development.
Cheng W; Jacobs WB; Zhang JJ; Moro A; Park JH; Kushida M; Qiu W; Mills AA; Kim PC
Development; 2006 Dec; 133(23):4783-92. PubMed ID: 17079275
[TBL] [Abstract][Full Text] [Related]
19. p63 null mutation protects mouse oocytes from radio-induced apoptosis.
Livera G; Petre-Lazar B; Guerquin MJ; Trautmann E; Coffigny H; Habert R
Reproduction; 2008 Jan; 135(1):3-12. PubMed ID: 18159078
[TBL] [Abstract][Full Text] [Related]
20. Expression of different p63 variants in healing skin wounds suggests a role of p63 in reepithelialization and muscle repair.
Bamberger C; Hafner A; Schmale H; Werner S
Wound Repair Regen; 2005; 13(1):41-50. PubMed ID: 15659035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
